FDA Adverse Event Malfunction Summary report: N

ID NOW COVID-19 2.0 TEST KIT 24T (EUA)

MDR report key: 19637057 · Received June 28, 2024

Report

Report Number
1221359-2024-00433
Event Type
Malfunction
Date Received
June 28, 2024
Date of Event
June 10, 2024
Report Date
July 8, 2024
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QWR
UDI-DI
00811877011354
PMA / PMN Number
K221925
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

D2A - COMMON DEVICE NAME: SIMPLE POINT-OF-CARE DEVICE TO DETECT SAR-COV-2 NUCLEIC ACID TARGETS FROM CLINICAL SPECIMENS IN NEAR-PATIENT SETTINGS TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT M821209 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 192-000/LOT M821209 AND TEST BASE PART NUMBER 192-430/LOT M821209. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT M821209 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE, HOWEVER A POSSIBLE ASSIGNABLE ROOT CAUSE COULD BE PATIENT SAMPLE INTERFERENCE.

Additional Manufacturer Narrative · 0

D2A - COMMON DEVICE NAME: SIMPLE POINT-OF-CARE DEVICE TO DETECT SAR-COV-2 NUCLEIC ACID TARGETS FROM CLINICAL SPECIMENS IN NEAR-PATIENT SETTINGS THE REMAINDER OF THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION OR UPON RECEIPT OF NEW INFORMATION.

Description of Event or Problem · 0

THE CUSTOMER REPORTED FALSE POSITIVE RESULTS WITH THE ID NOW COVID-19 2.0 ASSAY PERFORMED ON (B)(6) 2024 ON A NASAL SAMPLE USING THE KIT SWAB. THIS MANUFACTURER¿S REPORT ADDRESSES TEST TWO (2) OF TWO (2) FOR PATIENT THREE (3) OF THREE (3). THE CUSTOMER PERFORMED AN ADDITIONAL TEST ON THE SAME DAY ON A DIFFERENT ID NOW INSTRUMENT AND GENERATED A NEGATIVE RESULT. THE CUSTOMER CONFIRMED THERE WAS NO PATIENT HARM DUE TO THE TEST RESULTS. ADDITIONALLY, THE CUSTOMER CONFIRMED THERE WAS NO DELAY OR IMPACT IN THE PATIENT¿S TREATMENT.

Description of Event or Problem · 0

THE CUSTOMER REPORTED FALSE POSITIVE RESULTS WITH THE ID NOW COVID-19 2.0 ASSAY PERFORMED ON (B)(6) 2024 ON A NASAL SAMPLE USING THE KIT SWAB. THIS MANUFACTURER¿S REPORT ADDRESSES TEST TWO (2) OF TWO (2) FOR PATIENT THREE (3) OF THREE (3). THE CUSTOMER PERFORMED AN ADDITIONAL TEST ON THE SAME DAY ON A DIFFERENT ID NOW INSTRUMENT AND GENERATED A NEGATIVE RESULT. THE CUSTOMER CONFIRMED THERE WAS NO PATIENT HARM DUE TO THE TEST RESULTS. ADDITIONALLY, THE CUSTOMER CONFIRMED THERE WAS NO DELAY OR IMPACT IN THE PATIENT¿S TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2192504 ID NOW COVID-19 2.0 TEST KIT 24T (EUA) SIMPLE POINT-OF-CARE DEVICE TO DETECT SAR-COV-2 NUCLEIC ACID TARGETS QWR ABBOTT DIAGNOSTICS SCARBOROUGH, INC. M821209 00811877011354

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown